These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
822 related articles for article (PubMed ID: 29587864)
1. Outcome Measures in Rheumatology - Interventions for medication Adherence (OMERACT-Adherence) Core Domain Set for Trials of Interventions for Medication Adherence in Rheumatology: 5 Phase Study Protocol. Kelly A; Tong A; Tymms K; March L; Craig JC; De Vera M; Evans V; Hassett G; Toupin-April K; van den Bemt B; Teixeira-Pinto A; Alten R; Bartlett SJ; Campbell W; Dawson T; Gill M; Hebing R; Meara A; Nieuwlaat R; Shaw Y; Singh JA; Suarez-Almazor M; Sumpton D; Wong P; Christensen R; Beaton D; de Wit M; Tugwell P; Trials; 2018 Mar; 19(1):204. PubMed ID: 29587864 [TBL] [Abstract][Full Text] [Related]
2. Standardised Outcomes in Nephrology-Children and Adolescents (SONG-Kids): a protocol for establishing a core outcome set for children with chronic kidney disease. Tong A; Samuel S; Zappitelli M; Dart A; Furth S; Eddy A; Groothoff J; Webb NJ; Yap HK; Bockenhauer D; Sinha A; Alexander SI; Goldstein SL; Gipson DS; Hanson CS; Evangelidis N; Crowe S; Harris T; Hemmelgarn BR; Manns B; Gill J; Tugwell P; Van Biesen W; Wheeler DC; Winkelmayer WC; Craig JC; Trials; 2016 Aug; 17():401. PubMed ID: 27519274 [TBL] [Abstract][Full Text] [Related]
3. Strategies to promote implementation of core outcomes for medication adherence trials in rheumatology: A report from the OMERACT-Adherence Group. Kordkheili AM; Bekker C; Hoens AM; Voshaar M; Campbell W; Carmona L; de Wit M; March L; Nielsen SM; Shea BJ; Toupin-April K; Tugwell P; Tymms K; Kelly A; Semin Arthritis Rheum; 2024 Jun; 66():152411. PubMed ID: 38537323 [TBL] [Abstract][Full Text] [Related]
4. Addressing Challenges in Developing a Core Domain Set in Adherence Interventions in Rheumatology: A Report from the OMERACT-Adherence Group. Kelly A; Bartlett SJ; de Wit MP; Beaton DE; Dawson T; Evans V; Gill M; Hassett G; March L; Scholte-Voshaar M; Singh JA; Tong A; Tugwell P; Wong P; Tymms K J Rheumatol; 2019 Sep; 46(9):1202-1206. PubMed ID: 30647162 [TBL] [Abstract][Full Text] [Related]
5. Developing an OMERACT Core Outcome Set for Assessing Safety Components in Rheumatology Trials: The OMERACT Safety Working Group. Klokker L; Tugwell P; Furst DE; Devoe D; Williamson P; Terwee CB; Suarez-Almazor ME; Strand V; Woodworth T; Leong AL; Goel N; Boers M; Brooks PM; Simon LS; Christensen R J Rheumatol; 2017 Dec; 44(12):1916-1919. PubMed ID: 27744393 [TBL] [Abstract][Full Text] [Related]
6. Standardised Outcomes in Nephrology-Polycystic Kidney Disease (SONG-PKD): study protocol for establishing a core outcome set in polycystic kidney disease. Cho Y; Sautenet B; Rangan G; Craig JC; Ong ACM; Chapman A; Ahn C; Chen D; Coolican H; Kao JT; Gansevoort R; Perrone R; Harris T; Torres V; Pei Y; Kerr PG; Ryan J; Gutman T; Howell M; Ju A; Manera KE; Teixeira-Pinto A; Hamiwka LA; Tong A Trials; 2017 Nov; 18(1):560. PubMed ID: 29169385 [TBL] [Abstract][Full Text] [Related]
7. OMERACT Development of a Core Domain Set of Outcomes for Shared Decision-making Interventions. Toupin-April K; Barton JL; Fraenkel L; Meara A; Li LC; Brooks P; de Wit M; Stacey D; Légaré F; Shea B; Lyddiatt A; Hofstetter C; Christensen R; Scholte Voshaar M; Suarez-Almazor ME; Boonen A; Meade T; March L; Jull JE; Campbell W; Alten R; Karuranga S; Morgan EM; Kelly A; Kaufman J; Hill S; Maxwell LJ; Beaton D; El-Miedany Y; Mittoo S; Bartlett SJ; Singh JA; Tugwell PS J Rheumatol; 2019 Oct; 46(10):1409-1414. PubMed ID: 30709963 [TBL] [Abstract][Full Text] [Related]
8. A Preliminary Core Domain Set for Clinical Trials of Shoulder Disorders: A Report from the OMERACT 2016 Shoulder Core Outcome Set Special Interest Group. Buchbinder R; Page MJ; Huang H; Verhagen AP; Beaton D; Kopkow C; Lenza M; Jain NB; Richards B; Richards P; Voshaar M; van der Windt D; Gagnier JJ; J Rheumatol; 2017 Dec; 44(12):1880-1883. PubMed ID: 28089972 [TBL] [Abstract][Full Text] [Related]
9. Consensus Building in OMERACT: Recommendations for Use of the Delphi for Core Outcome Set Development. Humphrey-Murto S; Crew R; Shea B; Bartlett SJ; March L; Tugwell P; Maxwell LJ; Beaton D; Grosskleg S; de Wit M J Rheumatol; 2019 Aug; 46(8):1041-1046. PubMed ID: 30770512 [TBL] [Abstract][Full Text] [Related]
10. Toward the Development of a Core Set of Outcome Domains to Assess Shared Decision-making Interventions in Rheumatology: Results from an OMERACT Delphi Survey and Consensus Meeting. Toupin-April K; Barton J; Fraenkel L; Li LC; Brooks P; De Wit M; Stacey D; Légaré F; Meara A; Shea B; Lyddiatt A; Hofstetter C; Gossec L; Christensen R; Scholte-Voshaar M; Suarez-Almazor ME; Boonen A; Meade T; March L; Pohl C; Jull JE; Sivarajah S; Campbell W; Alten R; Karuranga S; Morgan E; Kaufman J; Hill S; Maxwell LJ; Welch V; Beaton D; El-Miedany Y; Tugwell PS J Rheumatol; 2017 Oct; 44(10):1544-1550. PubMed ID: 28765239 [TBL] [Abstract][Full Text] [Related]
11. Endorsement of the OMERACT core domain set for shared decision making interventions in rheumatology trials: Results from a multi-stepped consensus-building approach. Toupin-April K; Décary S; de Wit M; Meara A; Barton JL; Fraenkel L; Li LC; Brooks P; Shea B; Stacey D; Légaré F; Lydiatt A; Hofstetter C; Proulx L; Christensen R; Voshaar M; Suarez-Almazor ME; Boonen A; Meade T; March L; Jull JE; Campbell W; Alten R; Morgan EM; Kelly A; Kaufman J; Hill S; Maxwell LJ; Guillemin F; Beaton D; El-Miedany Y; Mittoo S; Westrich Robertson T; Bartlett SJ; Singh JA; Mannion M; Nasef SI; de Souza S; Boel A; Adebajo A; Arnaud L; Gill TK; Moholt E; Burt J; Jayatilleke A; Hmamouchi I; Carrott D; Blanco FJ; Mather K; Maharaj A; Sharma S; Caso F; Fong C; Fernandez AP; Mackie S; Nikiphorou E; Jones A; Greer-Smith R; Sloan VS; Akpabio A; Strand V; Umaefulam V; Monti S; Melburn C; Abaza N; Schultz K; Stones S; Kiwalkar S; Srinivasalu H; Constien D; King LK; Tugwell P Semin Arthritis Rheum; 2021 Jun; 51(3):593-600. PubMed ID: 33892937 [TBL] [Abstract][Full Text] [Related]
12. Establishing a core domain set to measure rheumatoid arthritis flares: report of the OMERACT 11 RA flare Workshop. Bykerk VP; Lie E; Bartlett SJ; Alten R; Boonen A; Christensen R; Furst DE; Hewlett S; Leong AL; Lyddiatt A; March L; May JE; Montie P; Orbai AM; Pohl C; Scholte Voshaar M; Woodworth T; Bingham CO; Choy EH J Rheumatol; 2014 Apr; 41(4):799-809. PubMed ID: 24584927 [TBL] [Abstract][Full Text] [Related]
13. Evidence for Updating the Core Domain Set of Outcome Measures for Juvenile Idiopathic Arthritis: Report from a Special Interest Group at OMERACT 2016. Morgan EM; Riebschleger MP; Horonjeff J; Consolaro A; Munro JE; Thornhill S; Beukelman T; Brunner HI; Creek EL; Harris JG; Horton DB; Lovell DJ; Mannion ML; Olson JC; Rahimi H; Gallo MC; Calandra S; Ravelli A; Ringold S; Shenoi S; Stinson J; Toupin-April K; Strand V; Bingham CO J Rheumatol; 2017 Dec; 44(12):1884-1888. PubMed ID: 28811355 [TBL] [Abstract][Full Text] [Related]
14. Consensus of the definitions of the OMERACT glucocorticoid impact core domain set for people with rheumatic and musculoskeletal diseases. Lyne SA; Yip K; Vasiliou VS; Katz DA; Richards P; Tieu J; Black RJ; Bridgewater S; Palmowski A; Beaton D; Maxwell LJ; Robson JC; Mackie SL; Goodman SM; Hill CL Semin Arthritis Rheum; 2024 Feb; 64():152338. PubMed ID: 38134623 [TBL] [Abstract][Full Text] [Related]
15. Developing an Outcome Measures in Rheumatology (OMERACT) Core set of Outcome Measures for FOot and ankle disorders in RheumaTic and musculoskeletal diseases (COMFORT): core domain set study protocol. Chapman LS; Redmond AC; Flurey CA; Richards P; Smith TO; Arnold JB; Beaton D; Conaghan PG; Golightly YM; Hannan MT; Hofstetter C; Maxwell LJ; Menz HB; Shea B; Tugwell P; Helliwell P; Siddle HJ Trials; 2023 Jan; 24(1):65. PubMed ID: 36709309 [TBL] [Abstract][Full Text] [Related]
16. Standardised outcomes in nephrology - Haemodialysis (SONG-HD): study protocol for establishing a core outcome set in haemodialysis. Tong A; Manns B; Hemmelgarn B; Wheeler DC; Tugwell P; Winkelmayer WC; van Biesen W; Crowe S; Kerr PG; Polkinghorne KR; Howard K; Pollock C; Hawley CM; Johnson DW; McDonald SP; Gallagher MP; Urquhart-Secord R; Craig JC; Trials; 2015 Aug; 16():364. PubMed ID: 26285819 [TBL] [Abstract][Full Text] [Related]
17. Development of a core outcome set for clinical trials in basal cell carcinoma: study protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey. Schlessinger DI; Iyengar S; Yanes AF; Lazaroff JM; Godinez-Puig V; Chen BR; Kurta AO; Henley JK; Chiren SG; Furlan KC; Schmitt J; Deckert S; Poon E; Sobanko JF; Cartee TV; Alam M; Maher IA Trials; 2017 Oct; 18(1):490. PubMed ID: 29061190 [TBL] [Abstract][Full Text] [Related]
19. Creation of a core outcome set for clinical trials of people with shoulder pain: a study protocol. Gagnier JJ; Page MJ; Huang H; Verhagen AP; Buchbinder R Trials; 2017 Jul; 18(1):336. PubMed ID: 28728574 [TBL] [Abstract][Full Text] [Related]
20. Identifying Possible Outcome Domains from Existing Outcome Measures to Inform an OMERACT Core Domain Set for Safety in Rheumatology Trials. Klokker L; Berthelsen DB; Woodworth T; Andersen KM; Furst DE; Devoe D; Williamson PR; Suarez-Almazor ME; Strand V; Leong AL; Goel N; Boers M; Brooks PM; March L; Sloan VS; Tugwell P; Simon LS; Christensen R J Rheumatol; 2019 Sep; 46(9):1173-1178. PubMed ID: 31043547 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]